Skip to main content
impaact logo Return to homepage
  • Contact
    • Directory
  • About
    • Mission
    • Network Structure
      • Leadership
    • Areas of Research
      • Cure & Immunotherapy
      • Brain & Mental Health
      • Therapeutics
      • Tuberculosis
      • Social Behavioral Scientific Core (SBSC)
    • Early Career Investigator Program
    • Staff Spotlights
    • Funding Acknowledgements
    • Network Sites
      • Study Site Map
  • Studies
    • Research and Study Opportunities
    • Submit a Research Proposal
    • IMPAACT Study Snapshots
  • Community Engagement
    • ICAB Leadership Group
    • IMPAACT Community Advisory Board (ICAB)
    • Operations Center Staff
    • Resources
      • Acronyms
    • Site Community Advisory Boards
    • Community Meetings and Webinars
  • News & Events
    • Events and Conferences
    • IMPAACT Annual Meeting
    • Newsletters
    • Past Conference Presentations
    • Spotlight Series
  • Resources
    • COVID-19 Resources
    • HIV/AIDS Network Coordination (HANC)
    • Lab Center
      • Laboratory Committees
      • Laboratory Guidance Documents
      • Laboratory Resources for Quality Management
      • MiLab Resources
      • Specimen Repository
    • Manual of Procedures
    • Media Release Form
    • Network Logos & Templates
    • Regulatory Resources
    • Training Opportunities
    • NIH Updates
  • Publications
    • Abstracts
    • Manuscripts
  • Enter a search term.
Back to Directory

Heather Sprenger

Email

sprenger@fstrf.org

Phone

716-834-0900 Ext. 7262

Institution

Frontier Science Foundation

Title

Laboratory Data Division Chief

Address

Frontier Science Foundation
4033 Maple Road
Amherst, NY 14226-1056
United States of America
Request an Update

Affiliated Studies

P1006: Effects of HAART on Immune Function

DAIDS Number

10036

Research Area

Other

Study Status

Concluded

P1072: Safety and Immunogenicity of a Live, Attenuated, Rotavirus Vaccine (RotaTeqâ„¢) in HIV-1 Infected and Uninfected Children Born to HIV-1 Infected Mothers

DAIDS Number

10638

Research Area

Complications & Comorbidities

Study Status

Concluded

P1011: Serostim Growth Hormone Dose-Finding Study in Children With HIV

DAIDS Number

10316

Research Area

Other

Study Status

Concluded

P1076: Impact of Oral Alendronate Therapy on BMD in HIV-Infected Children/Adolescents

DAIDS Number

10669

Research Area

Complications & Comorbidities

Study Status

Concluded

P1012: PK Study of Once Versus Twice Dosing with Combivir

DAIDS Number

10266

Research Area

Other

Study Status

Concluded
Show All
IMPAACT logo Return to homepage

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.

Stay connected with the IMPAACT Network

Follow IMPAACT

Sign up for our newsletter

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Sitemap Privacy Notice

© 2020 IMPAACT Network